CX3CR1 and neoplasm: The average tumor size and pulmonary metastasis rate were decreased in mice treated with CX3CR1+ NK cells alone relative to those treated with CX3CR1+NK cells combined with an anti-CX3CL1 antibody or an anti-CX3CR1 antibody (Figure 6C-E).